MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 584560 | Name: Lufironil

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Lufironil inhibits CCl4-induced liver fibrosis in rats and inhibits proline hydroxylase.

Chemical Structure

Lufironil
Lufironil
CAS#128075-79-6

Theoretical Analysis

MedKoo Cat#: 584560

Name: Lufironil

CAS#: 128075-79-6

Chemical Formula: C13H19N3O4

Exact Mass: 281.1376

Molecular Weight: 281.31

Elemental Analysis: C, 55.51; H, 6.81; N, 14.94; O, 22.75

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Lufironil; HOE 077; Lufironilo; Lufironilum
IUPAC/Chemical Name
N,N'-Bis(2-methoxyethyl)-2,4-pyridinedicarboxamide
InChi Key
JUCNGMPTCXPMNB-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H19N3O4/c1-19-7-5-15-12(17)10-3-4-14-11(9-10)13(18)16-6-8-20-2/h3-4,9H,5-8H2,1-2H3,(H,15,17)(H,16,18)
SMILES Code
O=C(C1=NC=CC(C(NCCOC)=O)=C1)NCCOC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 281.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Baader E, Bickel M, Damm D, Donaubauer HH, Fehlhaber HW, Grötsch H, Günzler V, Teetz V, Volz M. Interference in clinical laboratory tests, with special regard to the bilirubin assay: effects of a metabolite of the new prolyl 4-hydroxylase inhibitor, Lufironil. Eur J Clin Chem Clin Biochem. 1994 Jul;32(7):515-20. PubMed PMID: 7981331. 2: Okita K, Sakaida I, Hino K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology. 2002;62 Suppl 1:24-8. Review. PubMed PMID: 11868781. 3: Horn W. General pharmacology, toxicology and future clinical development of HOE 077. J Hepatol. 1991;13 Suppl 3:S63-5. Review. PubMed PMID: 1667670. 4: Wang YJ, Wang SS, Bickel M, Guenzler V, Gerl M, Bissell DM. Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: differential effects in males and females. Am J Pathol. 1998 Jan;152(1):279-87. PubMed PMID: 9422545; PubMed Central PMCID: PMC1858123. 5: Zhang WJ, Marx SK, Laue C, Hyder A, Juergensen A, Bickel M, Schrezenmeir J. HOE 077 reduces fibrotic overgrowth around the barium alginate microcapsules. Transplant Proc. 2000 Feb;32(1):206-9. PubMed PMID: 10701026. 6: Sakaida I, Uchida K, Hironaka K, Okita K. Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis. J Gastroenterol. 1999 Jun;34(3):376-7. PubMed PMID: 10433015. 7: Bickel M, Baader E, Brocks DG, Engelbart K, Günzler V, Schmidts HL, Vogel GH. Beneficial effects of inhibitors of prolyl 4-hydroxylase in CCl4-induced fibrosis of the liver in rats. J Hepatol. 1991;13 Suppl 3:S26-33; discussion S34. PubMed PMID: 1667666. 8: Böker K, Schwarting G, Kaule G, Günzler V, Schmidt E. Fibrosis of the liver in rats induced by bile duct ligation. Effects of inhibition by prolyl 4-hydroxylase. J Hepatol. 1991;13 Suppl 3:S35-40. PubMed PMID: 1667667. 9: Böker K, Schwarting G, Kaule G, Günzler V, Ohlendorf S, Schmidt E. [Experimental studies of the inhibition of fibrogenesis]. Z Gastroenterol. 1992 Mar;30 Suppl 1:43-5. German. PubMed PMID: 1333142. 10: Clément B, Chesné C, Satie AP, Guillouzo A. Effects of the prolyl 4-hydroxylase proinhibitor HOE 077 on human and rat hepatocytes in primary culture. J Hepatol. 1991;13 Suppl 3:S41-7. PubMed PMID: 1667668. 11: Matsumura Y, Sakaida I, Uchida K, Kimura T, Ishihara T, Okita K. Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. J Hepatol. 1997 Jul;27(1):185-92. PubMed PMID: 9252094. 12: Weidenbach H, Lerch MM, Turi S, Bachem M, Adler G. Failure of a prolyl 4-hydroxylase inhibitor to alter extracellular matrix deposition during experimental pancreatitis. Digestion. 1997;58(1):50-7. PubMed PMID: 9018010. 13: Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K. Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis. 1994 Oct;15(10):2201-6. PubMed PMID: 7955054. 14: Kellner HM, Volz M, Badder E, Kürzel GU, Eckert HG. Pharmacokinetics and metabolism of HOE 077. Preclinical studies. J Hepatol. 1991;13 Suppl 3:S48-61; discussion S62. PubMed PMID: 1667669. 15: Sakaida I, Okita K. New prolyl 4-hydroxylase inhibitor reduces procollagen gene expression and enzyme-altered lesions in rat liver cirrhosis. J Gastroenterol Hepatol. 1995;10 Suppl 1:S63-4. PubMed PMID: 8589346. 16: Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology. 1996 Apr;23(4):755-63. PubMed PMID: 8666329.